Adial Pharmaceuticals announced on November 5, 2024, the appointment of Vinay Shah as the company’s Chief Financial Officer, effective November 16, 2024. Mr. Shah brings over 25 years of experience in financial strategy, investor relations, and operational efficiency within the pharmaceutical, biopharmaceutical, and healthcare sectors.
Prior to joining Adial, Mr. Shah served as CFO at Virpax Pharmaceuticals, Inc., where he focused on fundraising and strategic initiatives. His background also includes integral roles at Aravive, Inc., where he helped raise over $150 million, and Pacira Pharmaceuticals, Inc., where he contributed to the company’s IPO.
Joseph Truluck, the outgoing CFO, notified the company of his resignation on November 1, 2024, to pursue other opportunities. Mr. Truluck will remain CFO until November 15, 2024, and has entered into a consulting agreement to ensure an orderly transition.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.